drugset / Trial / NCT00391534
EXTENT: EXtended Tolerability and Efficacy of a Novel Formulation of Oxcarbazepine in a Trial in Partial Epilepsy
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is intended to investigate the safety and efficacy of a novel formulation of oxcarbazepine that is released more slowly than the current formulation. The study medication will be used as a treatment against partial epilepsy.
Timeline
- Start
- 2006-10
- Primary completion
- 2009-11
- Completion
- 2009-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Oxcarbazepine | Small molecule | 1200 mg | — |
| Comparator | Oxcarbazepine | Small molecule | 1500 mg | — |
| Comparator | Oxcarbazepine | Small molecule | 1800 mg | — |
| Comparator | Oxcarbazepine | Small molecule | 2100 mg | — |
| Comparator | Oxcarbazepine | Small molecule | 2400 mg | — |
| Comparator | Oxcarbazepine | Small molecule | 2700 mg | — |